drugset / Trial / NCT00238043

Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia

NCT00238043

Phase 3 Unknown 2000 enrolled Ministry of Health, Malaysia
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to establish the long-term safety and efficacy of Biogeneric Epoetin, the attainability of therapeutic target for anaemia management, and the impact of Epoetin treatment on long-term health outcome and its cost effectiveness.

Timeline

Start
2005-08
Primary completion
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic